ADALIMUMAB EFFICACY IN CROHN'S DISEASE - WHY WEIGHT?

(1) Manchester Royal Infirmary, Gastroenterology, Manchester, United Kingdom

(2) Gastroenterology, MANCHESTERROYAL INFIRMARY, Manchester, United Kingdom



This item was part of the Anti-TNF in IBD: Mono versus combo - safety matters session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A81